The status of diabetes control and antidiabetic drug therapy in Japan-A cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1)

Diabetes Research and Clinical Practice

Volumn 73, Issue 2, 2006, Pages 198-204

  Kobayashi, Masashi ^a   Yamazaki, Katsuya ^a   Hirao, Koichi ^b   Oishi, Mariko ^c   Kanatsuka, Azuma ^d   Yamauchi, Mikio ^b   Takagi, Hirofumi ^e   Kawai, Koichi ^f  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HEC Science Clinic   (Japan)

^c Oishi Clinic   (Japan)

^d Chiba Central Medical Center   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f Kawai Clinic   (Japan)

Author keywords

Control status; Cross sectional survey; Drug therapy; Japan

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DATA ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLYCEMIC CONTROL; HEALTH SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; TIME SERIES ANALYSIS;

AGED; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; JAPAN; LIPIDS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TREATMENT OUTCOME;

EID: 33745250519     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.01.013     Document Type: Article

References (20)

1. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diab. Care 21 (1998) 1414-1431
2. Amos A.F., McCarty D.J., and Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diab. Med. 14 Suppl. (1997) S1-S85
3. Ministry of Welfare, Japan, Report of national survey of Diabetes, 2002.
4. Kobayashi M., Yamazaki K., and Hayashi R. Diabetes Campaign in Toyama prefecture and development of computerized diabetes care. Int. Diab. Monit. (1999) 34-37
5. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., et al. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus, Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diab. Res. Clin. Pract. 55 (2002) 65-85
6. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diab. Med. 15 (1998) 539-553
7. Japan Society for the Study of Obesity. The Examination Committee of criteria for 'Obesity Disease' in Japan. Circ. J. 66 (2004) 987-992
8. Guideline Committee of the Japan Diabetes Society: Japan Diabetes Society Guidelines for the Management of Diabetes based on Scientific Evidences (2004), Japan Diabetes Society, Nanzando (in Japanese)
9. Nitiyanant W., and Tandhanand S. The Diabcare-Asia 1998 study outcomes on control and complications in type 1 and type 2 diabetic patients. Curr. Med. Res. Opin. 18 (2002) 317-327
10. Chuang L.M., and Tsai S.T. The status of diabetes control in Asia-a cross-sectional survey of 24317 patients with diabetes mellitus in 1998. Diab. Med. 19 (2002) 978-985
11. Stratton I.M., and Adler A.I. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000) 405-412
12. Koro C.K., Bourgeois N., Bowlin S.J., and Fedder D.O. Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. A preliminary report. Diab. Care 27 (2004) 17-20
13. Saydah S.H., Fradkin J., and Cowie C.C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291 (2004) 335-342
14. Wens J., Casteren V.V., Vermeire E., Royen P.V., Pas L., and Denekens J. Diagnosis and treatment of type 2 diabetes in three Belgian regions. Registration via a network of sentinel general practices. Eur. J. Epidemiol. 17 (2001) 743-750
15. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
16. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 3252 (1998) 854-865
17. Delrome S., and Chiasson J.L. Acarbose in the prevention of cardiovascular disease in subjects with impaired glucose tolerance and type 2 diabetes mellitus. Curr. Opin. Phramacol. 5 (2005) 184-189 (Review)
18. Johnson J.L., Wolf S.L., and Kabadi U.M. Efficacy of insulin and sulfornylurea combination therapy in type 2 diabetes. A meta-analysis of the randomized placebo-controlled trials. Arch. Intern. Med. 156 (1996) 259-264
19. Chiasson J.L., Josse R.G., and Hunt J.A. The efficacy of acarbose in the treatment of patients with non-insulin dependent diabetes mellitus. Ann. Intern. Med. 121 (1994) 928-935
20. Riddle M.C., and Schneider J. The Glimepiride Combination Group: Beginning insulin treatment of obese patients with evening 70/30 insulin plus glimepiride versus insulin alone. Diab. Care 21 (1998) 1052-1057